Subjective Comfort With Multipurpose and Hydrogen Peroxide Lens Care Solutions in Soft Contact Lens Wearers

Sponsor
Alcon Research (Industry)
Overall Status
Completed
CT.gov ID
NCT01164865
Collaborator
(none)
78
2
6

Study Details

Study Description

Brief Summary

The purpose of this study was to assess comfort in soft contact lens wearers.

Condition or Disease Intervention/Treatment Phase
  • Device: OPTI-FREE RepleniSH multipurpose disinfecting solution
  • Device: Clear Care contact lens care system
  • Device: Contact lenses
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
78 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Supportive Care
Official Title:
The Subjective Comfort With Multipurpose and Hydrogen Peroxide Lens Care Solutions in Soft Contact Lens Wearers
Study Start Date :
Jun 1, 2010
Actual Primary Completion Date :
Dec 1, 2010
Actual Study Completion Date :
Dec 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: OPTI-FREE RepleniSH

OPTI-FREE RepleniSH multipurpose disinfecting solution used with study contact lenses on a daily basis for 2 weeks.

Device: OPTI-FREE RepleniSH multipurpose disinfecting solution
FDA-approved, multipurpose disinfecting solution used according to provided instructions for cleaning, rinsing, storing, and disinfecting study contact lenses on a daily basis, 2 weeks.
Other Names:
  • OPTI-FREE® RepleniSH®
  • Device: Contact lenses
    Contact lenses per subject's habitual brand and prescription worn every day for the duration of the study, 14 days, on a daily wear basis without scheduled replacement.

    Active Comparator: Clear Care

    Clear Care contact lens care system used with study contact lenses on a daily basis for 2 weeks.

    Device: Clear Care contact lens care system
    FDA-approved, hydrogen peroxide-based, lens care system used according to provided instructions for cleaning, disinfecting, daily protein removing, and storage of study contact lenses on a daily basis, 2 weeks.
    Other Names:
  • Clear Care®
  • Device: Contact lenses
    Contact lenses per subject's habitual brand and prescription worn every day for the duration of the study, 14 days, on a daily wear basis without scheduled replacement.

    Outcome Measures

    Primary Outcome Measures

    1. Change From Baseline in Ocular Comfort Rating at 2 Weeks [Baseline (Day 0), 2 weeks]

      Ocular comfort was rated by the participant on a continuous visual analog scale from 0-100, where 0=extremely uncomfortable, 50=neither comfortable nor uncomfortable, and 100=extremely comfortable. The participant marked a horizontal line across the scale at the point that best described "how your eyes feel right now."

    2. Likert Questionnaire Scores at 2 Weeks [2 weeks]

      The Likert Questionnaire included 8 questions on selected comfort measures. All responses were recorded on a 5-point scale, where 1=Strongly Disagree, 2=Disagree, 3=Undecided, 4=Agree, and 5=Strongly Agree.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Wear silicone hydrogel contact lenses on a daily wear basis;

    • Currently using OPTI-FREE RepleniSH contact lens solution;

    • Report comfort above 75 on a Visual Analog Scale at the Baseline Visit;

    • Read, sign, and date IRB-approved informed consent and the privacy document;

    • Be generally healthy and have normal ocular health;

    • Be be willing to follow the study procedures and visit schedule;

    • Other protocol-defined inclusion criteria may apply.

    Exclusion Criteria:
    • Use of additional lens cleaners;

    • Known sensitivity to any ingredient in either of the test articles;

    • Systemic or ocular disease or disorder (except refractive error) that would negatively affect the conduct or outcome of the study;

    • Prior (within 7 days of enrollment) or current ocular infections;

    • Clinically significant lash or lid abnormality;

    • History of ocular surgery/trauma within the last 6 months;

    • Use of any topical ocular or systemic antibiotics or corticosteroids within 7 days of enrollment;

    • Participation in any other ophthalmic drug or device clinical trial within 30 days of enrollment;

    • Other protocol-defined exclusion criteria may apply.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Alcon Research

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Alcon Research
    ClinicalTrials.gov Identifier:
    NCT01164865
    Other Study ID Numbers:
    • SMA-09-58
    First Posted:
    Jul 19, 2010
    Last Update Posted:
    Oct 12, 2012
    Last Verified:
    Sep 1, 2012
    Keywords provided by Alcon Research

    Study Results

    Participant Flow

    Recruitment Details Participants were recruited from two US study centers.
    Pre-assignment Detail
    Arm/Group Title OPTI-FREE RepleniSH Clear Care
    Arm/Group Description OPTI-FREE RepleniSH multipurpose disinfecting solution used with study contact lenses on a daily basis for 2 weeks. Clear Care contact lens care system used with study contact lenses on a daily basis for 2 weeks.
    Period Title: Overall Study
    STARTED 39 39
    COMPLETED 37 38
    NOT COMPLETED 2 1

    Baseline Characteristics

    Arm/Group Title OPTI-FREE RepleniSH Clear Care Total
    Arm/Group Description OPTI-FREE RepleniSH multipurpose disinfecting solution used with study contact lenses on a daily basis for 2 weeks. Clear Care contact lens care system used with study contact lenses on a daily basis for 2 weeks. Total of all reporting groups
    Overall Participants 39 39 78
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    37.1
    (12.27)
    41.5
    (9.59)
    39.3
    (11.16)
    Sex: Female, Male (Count of Participants)
    Female
    29
    74.4%
    26
    66.7%
    55
    70.5%
    Male
    10
    25.6%
    13
    33.3%
    23
    29.5%
    Region of Enrollment (participants) [Number]
    United States
    39
    100%
    39
    100%
    78
    100%

    Outcome Measures

    1. Primary Outcome
    Title Change From Baseline in Ocular Comfort Rating at 2 Weeks
    Description Ocular comfort was rated by the participant on a continuous visual analog scale from 0-100, where 0=extremely uncomfortable, 50=neither comfortable nor uncomfortable, and 100=extremely comfortable. The participant marked a horizontal line across the scale at the point that best described "how your eyes feel right now."
    Time Frame Baseline (Day 0), 2 weeks

    Outcome Measure Data

    Analysis Population Description
    All participants who received regimen, satisfied the inclusion/exclusion criteria, and completed the 14-day treatment period, including completion of the Visit 2 evaluations.
    Arm/Group Title OPTI-FREE RepleniSH Clear Care
    Arm/Group Description OPTI-FREE RepleniSH multipurpose disinfecting solution used with study contact lenses on a daily basis for 2 weeks. Clear Care contact lens care system used with study contact lenses on a daily basis for 2 weeks.
    Measure Participants 37 38
    Least Squares Mean (95% Confidence Interval) [Units on a scale]
    -8.20
    -7.14
    2. Primary Outcome
    Title Likert Questionnaire Scores at 2 Weeks
    Description The Likert Questionnaire included 8 questions on selected comfort measures. All responses were recorded on a 5-point scale, where 1=Strongly Disagree, 2=Disagree, 3=Undecided, 4=Agree, and 5=Strongly Agree.
    Time Frame 2 weeks

    Outcome Measure Data

    Analysis Population Description
    All participants who received regimen, satisfied the inclusion/exclusion criteria, and completed the 14-day treatment period, including completion of the Visit 2 evaluations.
    Arm/Group Title OPTI-FREE RepleniSH Clear Care
    Arm/Group Description OPTI-FREE RepleniSH multipurpose disinfecting solution used with study contact lenses on a daily basis for 2 weeks. Clear Care contact lens care system used with study contact lenses on a daily basis for 2 weeks.
    Measure Participants 37 38
    I can comfortably wear my lenses
    4.20
    4.24
    My lenses stay moist from morning to evening
    3.60
    3.69
    The solution I use feels gentle on my eyes
    4.00
    3.66
    My lenses feel fresh
    3.79
    4.03
    At the end of the day, my vision is clear
    3.54
    3.86
    When I put my lenses in, they feel comfortable
    4.05
    4.03
    I like the way this product feels during handling
    4.09
    3.66
    My lenses feel moist
    3.84
    3.64

    Adverse Events

    Time Frame Adverse events were collected for the duration of the study: 5 months, 3 weeks.
    Adverse Event Reporting Description The safety population included all enrolled and exposed participants.
    Arm/Group Title OPTI-FREE RepleniSH Clear Care
    Arm/Group Description OPTI-FREE RepleniSH multipurpose disinfecting solution used with study contact lenses on a daily basis for 2 weeks. Clear Care contact lens care system used with study contact lenses on a daily basis for 2 weeks.
    All Cause Mortality
    OPTI-FREE RepleniSH Clear Care
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total / (NaN) / (NaN)
    Serious Adverse Events
    OPTI-FREE RepleniSH Clear Care
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/39 (0%) 0/39 (0%)
    Other (Not Including Serious) Adverse Events
    OPTI-FREE RepleniSH Clear Care
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/39 (0%) 0/39 (0%)

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    Principal Investigators are NOT employed by the organization sponsoring the study.

    Alcon reserves the right of prior review of any publication or presentation of information related to the study.

    Results Point of Contact

    Name/Title Jami Kern, Ph.D.
    Organization Alcon Global Medical Affairs
    Phone 1-888-451-3937
    Email
    Responsible Party:
    Alcon Research
    ClinicalTrials.gov Identifier:
    NCT01164865
    Other Study ID Numbers:
    • SMA-09-58
    First Posted:
    Jul 19, 2010
    Last Update Posted:
    Oct 12, 2012
    Last Verified:
    Sep 1, 2012